Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 07/1/14 → 09/23/21 |
Funding
- Astellas Pharma Global Development Incorporated: $56,119.40
A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Trial Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ from a CMV-Seropositive Donor
- Kayler, Liise (PI)
- Pankewycz, Oleh (PI)
Project: Research